MedPath

Hyperbaric Oxygen Therapy Improves Outcome of Hypoxic-Ischemic Encephalopathy

Not Applicable
Conditions
Hypoxic-ischemic Encephalopathy
Registration Number
NCT02894866
Lead Sponsor
Nanfang Hospital, Southern Medical University
Brief Summary

The purpose of this study is to to evaluate the safety and efficacy of hyperbaric oxygen in term gestation newborn infants with hypoxic-ischemic encephalopathy..

Detailed Description

Hypoxic-ischemic encephalopathy (HIE) remains a major cause of neonatal death and long term disabilities. Data from animal studies have shown protective effects of hyperbaric oxygen therapy to impaired brain. Recently research priorities have moved from bench to bedside. Several studies have shown a trend for brain protection of hyperbaric oxygen therapy has emerged as a promising treatment for HIE. Therefore,the investigators organized a multi-centered randomized controlled trial of hyperbaric oxygen therapy in HIE newborn infants.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Newborn infants whose gestational age ≥37 weeks' gestation, weighing over 2500 g ;
    • Acute perinatal event (e.g., late or variable decelerations, cord prolapse, cord rupture, uterine rupture, maternal trauma, hemorrhage, or cardiorespiratory arrest)
    • With an Apgar score ≤ 3 at one minute and ≤5 at five minutes, and/or a potential of hydrogen of 7.0 or less or a base deficit of 16 mmol per liter or more in a sample of umbilical-cord blood or any blood during the first hour after birth.
    • Having moderate-to-severe encephalopathy (indicated by lethargy, stupor, or coma) and either hypotonia, abnormal reflexes (including oculomotor or pupillary abnormalities), an absent or weak suck, or clinical seizures, and/or have abnormal background activity of at least 20 minutes' duration or seizures on amplitude integrated electroencephalography
Exclusion Criteria
  • A congenital and the hereditary disease, a chromosome abnormalities, and a congenital abnormality.
    • During the acute phases of intracranial and (or) fundus hemorrhage. o
    • Intracranial infection.
    • Pneumothorax.
    • Infants who have been received hypothermia.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Number of Death or Moderate to Severe Disability Which is Graded According to Gross Motor Function Classification System (GMFCS)18 months of life

Number of Death or Moderate to Severe Disability Which is Graded According to

Secondary Outcome Measures
NameTimeMethod
Number of Infants with Brain-stem Auditory Evoked Potentials Abnormalities at 3 Months of Life3 months of life

Number of Infants with Brain-stem Auditory Evoked Potentials

Bayley Scales of Infant Development6,12 and 18 months of life

Bayley Scales of Infant Development

Number of Infants with abnormal ambulatory electroencephalography monitoring Abnormalities3 months of life

Number of Infants with abnormal ambulatory electroencephalography monitoring

Adverse Events That Are Related to Treatment3 months of life

fundus examination by ophthalmofunduscope to evaluate retinopathy of prematurity,chest radiograph to evaluate pneumothorax, and monitoring vital signs by neonatal monitor

Number of Infants with Brain Magnetic Resonance Imaging Abnormalities3 months of Lif

Number of Infants with Brain Magnetic Resonance Imaging Abnormalities

neonatal behavioral neurological assessment7,14 and 28 days after birth

neonatal behavioral neurological assessment

Gross Motor Function Classification System18 months of life

Gross Motor Function Classification System

Trial Locations

Locations (10)

Xiamen Maternity and Child Healthcare Hospital

🇨🇳

Xiamen, Fujian, China

Nanfang Hospital of Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

The Third Affiliated Hospital of Guangzhou Medical University

🇨🇳

Guangzhou, Guangdong, China

Zhujiang Hospital of Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

Shenzhen Maternity and Child Healthcare Hospital

🇨🇳

Shenzhen, Guangdong, China

Shenzhen People's Hospital

🇨🇳

Shenzhen, Guangdong, China

The Maternity and Child Healthcare Hospital of Guangxi Zhuang Autonomous Region

🇨🇳

Guangxi, Guangxi, China

Hunan Children's hospital

🇨🇳

Changsha, Hunan, China

The First Hospital of Jilin University

🇨🇳

Jilin, Jilin, China

Chengdu Women and Children's central hospital

🇨🇳

Chengdu, Sichuan, China

Xiamen Maternity and Child Healthcare Hospital
🇨🇳Xiamen, Fujian, China
Xingzhu Lin
Contact
xinzhufj@163.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.